Key result
Intestine-specific Dgat1 deficiency in ApoE-/- mice attenuates atherogenesis by reducing dietary cholesterol absorption.
Why the study?
Following findings that whole-body Dgat1 deficiency attenuated atherogenesis while hematopoietic deficiency did not, the role of intestinal Dgat1 deficiency in regulating atherogenesis remained to be delineated.
Does intestine-specific Dgat1 deficiency reduce atherosclerosis and systemic cholesterol burden in ApoE-/- mice?
Does intestine-specific Dgat1 deficiency reduce atherosclerosis and systemic cholesterol burden in ApoE-/- mice?
Intestine-specific DGAT1 deficiency reduces systemic cholesterol and attenuates atherosclerosis in a mouse model, highlighting intestinal DGAT1 as a potential therapeutic target for cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for DGAT1 inhibition in hypercholesterolemia; should not yet change clinical practice.
Background and aims Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) is the rate-limiting enzyme catalyzing the final step of triglyceride synthesis by esterifying a diglyceride with a fatty acid. We have previously shown that apolipoprotein E-knockout ( ApoE −/− ) mice lacking Dgat1 have reduced intestinal cholesterol absorption and potentiated macrophage cholesterol efflux, and consequently, exhibit attenuated atherogenesis. However, hematopoietic Dgat1 deficiency lacked beneficial effects on atherosclerosis. Due to our recent results on the critical role of intestinal Dgat1 in murine cholesterol homeostasis, we delineated whether intestinal Dgat1 deficiency regulates atherogenesis in mice. Methods We generated intestine-specific Dgat1 −/− mice on the ApoE −/− background ( iDgat1 −/− ApoE −/− ) and determined cholesterol homeostasis and atherosclerosis development. Results When fed a Western-type diet, iDgat1 −/− ApoE −/− mice exhibited a substantial decrease in fasting plasma cholesterol content in ApoB-containing lipoproteins. Although lipid absorption was delayed, iDgat1 −/− ApoE −/− mice had reduced acute and fractional cholesterol absorption coupled with an elevated fecal caloric loss. In line, increased appearance of i.v. administered [³H]cholesterol in duodena and stool of iDgat1 −/− ApoE −/− animals suggested potentiated cholesterol elimination. Atherosclerotic lesions were markedly smaller with beneficial alterations in plaque composition as evidenced by reduced macrophage infiltration and necrotic core size despite unaltered collagen content, indicating improved plaque stability. Conclusions Disruption of Dgat1 activity solely in the small intestine of ApoE −/− mice strongly decreased plasma cholesterol levels by abrogating the assimilation of dietary cholesterol, partly by reduced absorption and increased excretion. Consequently, the reduced cholesterol burden significantly attenuated atherogenesis and improved the lesion phenotype in iDgat1 −/− ApoE −/− mice.
No takes yet. Share an insight, caveat, or question.
Vujić et al. (2020) studied Atherosclerosis. Intestine-specific Dgat1 deficiency vs. ApoE-/- mice with intact Dgat1 was evaluated on Atherosclerosis development and plasma cholesterol content. Intestine-specific Dgat1 deficiency in ApoE-/- mice strongly decreased plasma cholesterol levels and significantly attenuated atherogenesis by reducing dietary cholesterol absorption.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: